Arthur Tzianabos - 20 Mar 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Interim Executive Chair, Director
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
20 Mar 2025
Net transactions value
$0
Form type
4
Filing time
20 Mar 2025, 18:18:36 UTC
Previous filing
27 Feb 2025
Next filing
27 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Stock Option (Right to Buy) Award $0 +122,651 $0.000000 122,651 20 Mar 2025 Common Stock 122,651 $8.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.